3.0 
Hidden risk is like a ticking bomb in your portfolio.
Control the damage before it's too late!
FREE Portfolio Health Check Available on ET Money app
Get a free quote
Scan the QR Code to download the ET Money app
- To scan the QR code you can use a QR code scanner app or your smartphone camera using Google lens.
- After downloading the app, explore our products to help you live your choices.
Mutual Funds
Genius
Insurance
Calculators
Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
Prudential Technology Bluechip FundFind out how much and how long you should invest in it to suit your overall portfolio
Knowing this helps you control risk in your portfolio
Your investor personality Adventurer
You confirm that you have seen and understood your investor personality by entering the OTP.
Enter OTP to acknowledge
OTP sent to
Tata India Pharma & HealthCare Fund Direct-Growth
NAV as of(Aug 11, 2023)
₹ 22.82 -1.27 % 1-D Change
Returns 
11.37% p.a.
You get upto 1.42%extra returns
- Monthly SIP
Monthly SIP is not available for this fund - Lumpsum Lumpsum is not available for this fund
₹
Minimum SIP amount is ₹
₹
Minimum Lumpsum amount is ₹
This fund vs
Show performance of:
Scheme Details
| VRO Rating | |
| Expense ratio | 0.97% As on Jun 30, 2023 |
| Exit Load | 0.25% |
| AUM (Fund Size) | ₹ 641 Crs |
| Lock-in | No Lockin |
| Age | 7 yrs 8 m Since Dec 04, 2015 |
| Benchmark | NIFTY Pharma TRI |
| Min. Investment | SIP ₹500 & Lumpsum ₹5000 |
About Tata India Pharma & HealthCare Fund
Tata India Pharma & HealthCare Fund Direct-Growth is a Sectoral-Pharma mutual fund scheme from Tata Mutual Fund. This fund has been in existence for 7 yrs 8 m, having been launched on 04/12/2015. Tata India Pharma & HealthCare Fund Direct-Growth has ₹641 Crores worth of assets under management (AUM) as on 30/06/2023 and is medium-sized fund of its category. The fund has an expense ratio of 0.97%, which is close to what most other Sectoral-pharma funds charge.
.....- Tata India Pharma & HealthCare Fund Direct-Growth returns of last 1-year are 23.82%. Since launch, it has delivered 11.43% average annual returns. The fund has doubled the money invested in it every 4 yrs.
- Tata India Pharma & HealthCare Fund Direct-Growth scheme's ability to deliver returns consistently is in-line with most funds of its category. Its ability to control losses in a falling market is high.
- The fund has the majority of its money invested in Healthcare, Chemicals sectors. It has taken less exposure in Healthcare, Chemicals sectors compared to other funds in the category.
- The fund's top 5 holdings are in Sun Pharmaceutical Inds. Ltd., Dr. Reddy's Laboratories Ltd., Lupin Ltd., Cipla Ltd., Aurobindo Pharma Ltd..
Investment Returns Calculator
of
for
Invested
Profit
| Total value | Profit | ||
|---|---|---|---|
This fund | |||
Category Average | |||
Bank FD | |||
Gold |
Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully. Past performance is not an indicator of future returns.
Latest Asset & Portfolio Allocation
as on Jul 31, 2023Top Stock Holdings
Allocation by Market Cap
Large Cap 44.14%
Mid Cap 34.51%
Small Cap 18.74%
Other Cap 0%
Allocation by Sector
Healthcare 96.52%
Chemicals 0.85%
Top Debt Holdings
Bifurcation by Holding is not available for this fund
Allocation by Credit Quality
Bifurcation by Credit Quality is not available for this fund
Allocation by Instruments
Cash/Net Current Assets 2.36%
Repo 0.25%
Other Holdings
Others 0.25%
Want to know in detail about the portfolio of this fund?
Comparison with sectoral-pharma Funds
as on Aug 14, 2023| Fund name | Annual Return % | ||
|---|---|---|---|
| Mirae Asset Healthcare Fund | 21.48% | ||
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 19.76% | ||
| SBI Healthcare Opportunities Fund | 19.5% | ||
| Nippon India Pharma Fund | 19.44% | ||
| Tata India Pharma & HealthCare Fund | 19.23% | ||
| UTI Healthcare Fund | 16.78% |
Trailing Returns and Ranks
as on Aug 14, 2023| Period | Trailing returns | Category average |
|---|---|---|
| 1 month | 8.52% | 7.18% |
| 3 months | 21.78% | 21.22% |
| 6 months | 25.46% | 25.95% |
| 1 year | 24.32% | 24.57% |
| 3 years | 17.3% | 16.94% |
| 5 years | 19.23% | 19.37% |
Want to know in detail about the returns of this fund?
Riskometer
Level of Risk in the Scheme
Investors understand that their principal will be at Very High risk
Tata India Pharma & HealthCare Fund
EQUITY SECTORAL-PHARMA
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
- Std. Dev : 14.55
- Alpha : 3.33
- Beta : 0.91
- Sharpe : 0.95
- Sortino : 1.96
Meeta Shetty
Ms. Shetty is Bachelor in Economics and CFA Charterholder
Prior to joining TATA Mutual Fund, she has worked with Kotak Securities, HDFC Securities, AMSEC(Asian Market Securities), Dalal & Broacha Stock Broking and karvey Stock Broking.
Tata Mutual Fund
TOTAL AUM:
₹1,11,185 Crs
As on Jun 30, 2023
- Email: service@tataamc.com
- Phone: 1800-209-0101
- Address: 9th Floor, Mafatlal Centre,
Nariman Point,
Mumbai, 400021
Compare with similar Funds
Frequently Asked questions
How fund report card works
Identifying a top performing fund that consistently creates wealth can be a challenging task due to the dynamic nature of the market. Top funds often change frequently, sometimes even on a daily basis.
However, with ET Money's fund report card, it is now possible to find a fund that consistently ranks at the top and generates wealth over a long period of time. This valuable resource makes it easier to navigate the complex and constantly changing world of financial markets.
At ET Money, we have developed a smart ranking system for funds based on their consistency. We believe that consistently performing at the top of a category is more important than just occasionally ranking highly. To evaluate the consistency of a fund, we have identified two key parameters: "consistency of returns" and "protection from volatility." We assess these parameters by analyzing the strong performance and low volatility of a fund over a prolonged period of time. To arrive at a rating for these parameters, we carefully consider the track record of a fund in terms of both performance and volatility.
In our ranking methodology, we prioritize funds that consistently perform well over those that fluctuate in their performance. To ensure stability in our rankings, we analyzed data for a minimum of five years, rather than just a year or two. We also placed a greater emphasis on recent performance, as it tends to have a greater impact on momentum. This allows us to capture the full potential of recent momentum in our rankings.
How are the returns of Tata India Pharma & HealthCare Fund ?
The Tata India Pharma & HealthCare Fund is a 7 yrs 8 m old fund and has delivered average annual returns of 11.37% since inception.
Tata India Pharma & HealthCare Fund Returns
| 1-Year | 3-Year | 5-Year | Since Inception |
|---|---|---|---|
| 24.32% | 17.3% | 19.23% | 11.37% |
What is the current NAV of Tata India Pharma & HealthCare Fund?
NAV or Net Asset Value is the per-unit price of the Mutual Fund. The NAV of a Mutual Fund changes every day. It is calculated by taking the current value of the holdings of the fund at end of the day, subtracting the expenses, and dividing the value by the number of units issued to date.
The NAV of Tata India Pharma & HealthCare Fund for Aug 11, 2023 is 22.82.
How do I invest in Tata India Pharma & HealthCare Fund?
On ET Money, Investing in Tata India Pharma & HealthCare Fund is fast, easy, and 100% paperless. And it takes only minutes. Here is what you need to do -
- Click on the Invest Now Button present on the top right-hand side.
- Enter your email id, select whether you want to do a one-time investment or start a SIP and add the amount
- Provide few more details needed including the bank account from which you will be making the payment and confirm.
- That's it. Your SIP or one-time investment in Tata India Pharma & HealthCare Fund is done.
How much does Tata India Pharma & HealthCare Fund charge as expense ratio?
The Expense Ratio of a Mutual Fund is the annual charges you pay to the Mutual Fund company for managing your investments in that fund. The Expense Ratio is a percentage of Assets Under Management (AUM) and is taken from the returns generated by the fund. For this reason, a fund with a lower expense ratio is always better because a smaller part of the returns will be taken and that means more returns for you.
The Expense Ratio of the direct plan of Tata India Pharma & HealthCare Fund is 0.97%. .
How can I redeem my investments in Tata India Pharma & HealthCare Fund?
Redeeming your investments in Tata India Pharma & HealthCare Fund is super easy. If you have invested in this fund via ET Money, just login into the app, go to the investment section and put the redemption request.
If you have invested in Tata India Pharma & HealthCare Fund from anywhere else, you can go to the fund house website and put a request through it.
What is the AUM or size of Tata India Pharma & HealthCare Fund?
AUM or Asset Under Management is the total value of the assets held by a Mutual Fund scheme. For instance, for an equity Mutual Fund, the AUM will be the total value of its portfolio's equity shares (plus any other asset it might have invested in). The AUM of the fund changes every day because the price of the underlying asset fluctuates daily. However, the Mutual Fund company doesn't update it every day. It is updated only at the end of the month and released within few days of the next month.
The AUM of the fund is a good indicator of its popularity. A fund with a high AUM means a lot of money has been invested in it, and investors like it. However, the AUM should never be the primary criteria while selecting a fund. There are funds with huge AUMs that continue to perform well despite their size.
The AUM of Tata India Pharma & HealthCare Fund is ₹641 Crs.
What are the top stock holdings of Tata India Pharma & HealthCare Fund?
The Tata India Pharma & HealthCare Fund has invested the majority of its money in the stocks of the following companies -
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceutical Inds. Ltd. | 13.19% |
| Dr. Reddy's Laboratories Ltd. | 10.28% |
| Lupin Ltd. | 9.89% |
| Cipla Ltd. | 7.43% |
| Aurobindo Pharma Ltd. | 7.2% |
| Divi's Laboratories Ltd. | 6.03% |
| Alkem Laboratories Ltd. | 5.16% |
| Fortis Healthcare (India) Ltd | 4.61% |
| Apollo Hospitals Enterprise Ltd. | 3.87% |
| Zydus Lifesciences Ltd. | 3.74% |
What are the top sectors Tata India Pharma & HealthCare Fund has invested in?
The Tata India Pharma & HealthCare Fund has primarily invested in the following sectors
| Sector | Percentage of Portfolio |
|---|---|
| Healthcare | 96.52% |
| Chemicals | 0.85% |